King & Spalding represented Apollo in an investment via its Hybrid Value funds in PanAsia Health Limited, the holding company for Health Management International Pte Ltd (HMI).
HMI is a fast-growing Singapore-based regional healthcare provider. It has two hospitals in Malaysia, Mahkota Medical Centre and Regency Specialist Hospital, as well as investments in Singapore, including the first private one-stop ambulatory care centre in the country, StarMed Specialist Centre, the largest private ophthalmology chain in Singapore, Eagle Eye Centre, a nationwide primary care clinic chain, OneCare Medical, and a leading medical benefits administrator, MHC Asia Group.
The investment continues the strong pace of activity of Apollo’s Hybrid Value strategy, which has led more than $18 billion of investment commitments since inception. More details can be found here.